Kuyinkulumompikiswano yangempela osekuphele izinyanga iqhubeka maqondana nokuba semthethweni kokumaketha kwe "CBD" edumile (Cannabidiol). Amasampula aqukethe le nto cannabinoid, evela ezitshalweni ze-cannabis ezivinjelwe eFrance, imvamisa iqukethe iminonjana ye-THC (tetrahydrocannabinol). Le nto ye-psychoactive, ebhekele engcupheni yokuncika kwe-cannabis, ayivunyelwe ukusetshenziswa nokudayiswa eFrance.
INDLELA YANGEMPELA YOKUKWETHULA IZIMO EZITHILE ZOKWELAPHA
NgoJuni 2018, i-MILDECA (I-Interministerial Mission for the Fight against Drugs and Addictive Behaviours), ngesikhathi somhlangano. isibuyekezo ngomthetho ukhumbule ukuthi i-cannabidiol ayiyona insangu esemthethweni, nokuthi ukusetshenziswa kwalokhu kokugcina akufanele kukhuthazwe noma kuthengiswe ngaphansi kwesicabha sobuhle bokwelapha, lokhu kukhuthazwa kugcinelwe izidakamizwa ezigunyaziwe kuphela.
Ngaphansi kwalezi zimo, ukuthengiswa kwale mikhiqizo esekwe ku-cannabidiol akuvunyelwe eFrance, kuyilapho into ngokwayo ingekho. Kodwa-ke, kunezinkomba zokuthi i-cannabidiol ingaba usizo ezimweni ezithile zezokwelapha, ikakhulukazi ekwelapheni isithuthwane.
Izigaba ezine zabasebenzisi abaphethwe isifo zingase zizwe zikhathazekile ngalokhu kusetshenziswa kwe-cannabidiol. Abambalwa kakhulu, kodwa abasengozini enkulu, kungaba izingane ezinesifo sokuwa ezingalawulwa kahle ngemithi evamile. Abanye abazali ngokusemthethweni bafuna zonke izixazululo ezingaba khona ukuze banciphise ukushuba kanye nokuvama kokuquleka. Izifundo eziningi ku-intshisekelo ye-cannabidiol kulesi sifo (okuvame ukuhlotshaniswa nesidakamizwa esilwa nesifo sokuwa) kungabaholela ekunikezeni izingane zabo imikhiqizo equkethe i-cannabidiol ngaphandle kokwazi ikhwalithi ngempela.
Isibalo sesibili yilabo abasebenzisa insangu. Inamalungu amaningi ngaphezulu, uma kubhekwa ukwanda kwalokhu kusetshenziswa eFrance. Imikhiqizo ye-cannabidiol, evame ukuhloswe ukuthi ibhenywe noma ifakwe i-vaped, inikezwa ngamanga kulaba bantu njengengxenye esemthethweni ye-cannabis, noma njengosizo lokuhoxiswa.
Isibalo sesithathu, sabantu abanenkinga yokuphazamiseka kwengqondo (ukukhathazeka okungapheli, ukucindezeleka okungapheli noma ngisho nengqondo), bangase balingeke ukuba badle i-cannabidiol befuna umphumela we-anxiolytic noma antipsychotic, noma ngisho nokuphazamisa ukwelashwa kwabo kwezidakamizwa.
Okokugcina, inani lesine labantu okungenzeka livezwe ku-cannabidiol lizohlanganisa abantu asebekhulile abahlushwa ubuhlungu obuncane futhi bafuna ezinye izindlela zokuxazulula izixazululo zezidakamizwa.
Esimeni sokungathembani okukhulayo kwezidakamizwa kanye nemithi ye-allopathic, esekelwe ebufakazini, inani elikhulayo labantu lifuna izixazululo ezingezona izidakamizwa, ngokuvamile ezemvelo. Ngakho banikezwa amalungiselelo asekelwe ku-cannabidiol ezitolo, ku-inthanethi noma komagazini abathile.
I-CanNABIDIOL, INTO EYETHULA INGOZI?
Umkhiqizo wokuqala wokwelapha osuselwa ekukhishweni kwe-cannabis (Epidiolex®), oqukethe i-cannabidiol, otholwe kulo nyaka. e-United States isigunyazo sokumaketha ekwelapheni izifo ezingavamile zesithuthwane ezinganeni, ngaphezu kokwelashwa okukhona kwe-antiepileptic. Isicelo sihlolwa yi-European Medicines Agency (EMA) kulo muthi, okunikeza ithemba lokuthi kungenzeka kwenziwe uhwebo phakathi no-2019.
Kodwa-ke, ucwaningo lwemitholampilo ngale molecule luphinde lwabika, phakathi kwemiphumela emibi evame kakhulu, ubungozi bokukhathala, ukozela kanye nokukhathala. Ngokuvamile i-cannabidiol izohlotshaniswa nenye into ebambezela ukusebenza kobuchopho njengotshwala, insangu noma izidakamizwa ezithile ze-psychotropic ezifana ne-anxiolytics, amaphilisi okulala, ama-opioid analgesics.
Ngakolunye uhlangothi, kucatshangelwa ulwazi lwamanje lwesayensi, ubungozi bokuncika noma ukuluthwa yi-cannabidiol abuboniswanga ngokucacile. Lokhu kwaqinisekiswa ngoJuni 2018 ngabakwa- Ibhodi Lokubuyekeza Ukuthembela Kwezidakamizwa Yenhlangano Yezempilo Yomhlaba. Le nto futhi ayiyona isihloko sombiko ngalo mqondo ovela kuziphathimandla zezempilo zaseFrance.
Umthombo : Theconversation.com/
